KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Other Operating Expenses (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Other Operating Expenses for 4 consecutive years, with $93000.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Other Operating Expenses fell 98.67% year-over-year to $93000.0, compared with a TTM value of $9.1 million through Dec 2023, up 19.7%, and an annual FY2025 reading of -$4.5 million, down 216.98% over the prior year.
  • Other Operating Expenses was $93000.0 for Q4 2023 at Ginkgo Bioworks Holdings, down from $2.9 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $87.9 million in Q4 2020 and bottomed at -$5.9 million in Q3 2020.
  • Average Other Operating Expenses over 4 years is $6.9 million, with a median of $1.1 million recorded in 2022.
  • The sharpest move saw Other Operating Expenses tumbled 102.95% in 2021, then skyrocketed 1301.74% in 2023.
  • Year by year, Other Operating Expenses stood at $87.9 million in 2020, then plummeted by 102.95% to -$2.6 million in 2021, then skyrocketed by 369.84% to $7.0 million in 2022, then crashed by 98.67% to $93000.0 in 2023.
  • Business Quant data shows Other Operating Expenses for DNA at $93000.0 in Q4 2023, $2.9 million in Q3 2023, and $3.2 million in Q2 2023.